mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
2026-08-20
原文 →
找到 2 篇相关文章
The vaccine reportedly thwarted the cancer's return and spread.
It took just hours for the leading pharma group to reject the recommendations.